Idiopathic inflammatory myopathies
IE Lundberg, M Fujimoto, J Vencovsky… - Nature Reviews …, 2021 - nature.com
Idiopathic inflammatory myopathies (IIM), also known as myositis, are a heterogeneous
group of autoimmune disorders with varying clinical manifestations, treatment responses …
group of autoimmune disorders with varying clinical manifestations, treatment responses …
Inflammatory muscle diseases
MC Dalakas - New England Journal of Medicine, 2015 - Mass Medical Soc
Inflammatory Muscle Diseases | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …
Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Z Betteridge, N McHugh - Journal of internal medicine, 2016 - Wiley Online Library
The idiopathic inflammatory myopathies are characterized by muscle weakness, skin
disease and internal organ involvement. Autoimmunity is known to have a role in myositis …
disease and internal organ involvement. Autoimmunity is known to have a role in myositis …
Classification and management of adult inflammatory myopathies
A Selva-O'Callaghan, I Pinal-Fernandez… - The Lancet …, 2018 - thelancet.com
Inflammatory myopathies, collectively known as myositis, are heterogeneous disorders
characterised by muscle inflammation, and frequently accompanied by extramuscular …
characterised by muscle inflammation, and frequently accompanied by extramuscular …
Dermatomyositis: clinical features and pathogenesis
ME DeWane, R Waldman, J Lu - Journal of the American Academy of …, 2020 - Elsevier
Dermatomyositis (DM) is an idiopathic inflammatory myopathy that is clinically
heterogeneous and that can be difficult to diagnose. Cutaneous manifestations sometimes …
heterogeneous and that can be difficult to diagnose. Cutaneous manifestations sometimes …
Rheumatic and musculoskeletal immune‐related adverse events due to immune checkpoint inhibitors: a systematic review of the literature
LC Cappelli, AK Gutierrez… - Arthritis care & …, 2017 - Wiley Online Library
Objective Immune checkpoint inhibitors (ICI s) are improving prognoses in advanced stage
cancers, but they also lead to immune‐related adverse events (IRAE s). IRAE s targeting …
cancers, but they also lead to immune‐related adverse events (IRAE s). IRAE s targeting …
[HTML][HTML] Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy …
Objectives To determine prevalence and co-existence of myositis specific autoantibodies
(MSAs) and myositis associated autoantibodies (MAAs) and associated clinical …
(MSAs) and myositis associated autoantibodies (MAAs) and associated clinical …
A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy
Autoantibodies specific for idiopathic inflammatory myopathy (myositis-specific
autoantibodies (MSAs)) are clinically useful biomarkers to help the diagnosis of …
autoantibodies (MSAs)) are clinically useful biomarkers to help the diagnosis of …
Autoantibodies in myositis
NJ McHugh, SL Tansley - Nature Reviews Rheumatology, 2018 - nature.com
The discovery of novel autoantigen systems related to idiopathic inflammatory myopathies
(collectively referred to as myositis) in adults and children has had major implications for the …
(collectively referred to as myositis) in adults and children has had major implications for the …
239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
Idiopathic inflammatory myopathies (IIM) are a heterogenous family of diseases that can
affect the muscles, skin, lungs, and joints. There have been prior attempts to classify IIMs …
affect the muscles, skin, lungs, and joints. There have been prior attempts to classify IIMs …